Radiotherapy & Oncology
Volume 102, Issue 3 , Pages 355-363, March 2012

IGRT induced dose burden for a variety of imaging protocols at two different anatomical sites

Division of Medical Radiation Physics, Department of Radiotherapy, Medical University Vienna, Austria

Received 21 March 2011; received in revised form 23 September 2011; accepted 16 October 2011. published online 18 November 2011.

Abstract 

Background and purpose

Increase in positioning accuracy and treatment adaptation is supported by image guidance. The downside is the concomitant imaging dose. In this study, we report on the total dose picture for different styles of image guidance.

Materials and methods

Dose was measured in the Alderson phantom using TLD’s. IGRT technology investigated included CBCT at the linac and simulator, multislice-CT and kV and MV planar imaging. Clinically used imaging protocols were applied and the total dose picture was assessed for four different sequences of imaging for a prostate and a head and neck treatment.

Results

The different imaging geometries for the various imaging modalities resulted in fairly different dose distributions. Head and neck doses up to 100mGy and higher were found for portal imaging and multislice-CT. Depending on the IGRT sequence used maximum total dose varies between 120 and 1500mGy. In prostate maximum doses between 40 and 100mGy were found for portal imaging and CBCT at the linac. Here the maximum total dose varies between 120 and 2250mGy depending on the sequence used.

Discussion

Factors like patient dimensions, age and sex can influence the applicability of presented values. Careful consideration of imaging dose especially for very intense imaging sequences is recommended.

Keywords: IGRT, Dosimetry, Head and neck, Prostate, ART, IMRT

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0167-8140(11)00607-4

doi:10.1016/j.radonc.2011.10.005

Radiotherapy & Oncology
Volume 102, Issue 3 , Pages 355-363, March 2012